Stay updated on Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, representing a deployed update to the ClinicalTrials.gov interface without changing the study information.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page has been updated to a new software/site revision (Revision v3.5.3 instead of v3.5.2). This reflects a version change rather than an update to the clinical study details.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded Marinesco-Sjögren syndrome and the Genetic and Rare Diseases Information Center as related resources.SummaryDifference0.2%

- Check64 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check71 days agoChange Detected- The revision tag on the page updated from v3.4.2 to v3.4.3. No visible content changes are indicated.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.